RxDoctor Payments Data

Joanna Bruno, MD

Internal Medicine · North Canton, OHNPI 1255300281

Payments from drug & device makers

$438in general payments, 2019–2025

Across 34 payments — averaging $12.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Merck$114
  • Amgen$61
  • Astellas Pharma US Inc$55
  • Pfizer$47
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$28
  • AstraZeneca$22
  • plus $110 from 7 others

What the payments were for

  • Food & beverage$438100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$438 in reported general payments places this provider in the 60th percentile of 4,428 internal medicine providers in Ohio.

See all internal medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$102,543
Medicare patients
303
Services billed
2,089

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban221$193,362
JardianceEmpagliflozin119$119,681
JanuviaSitagliptin Phosphate85$87,289
XareltoRivaroxaban52$58,665
TrulicityDulaglutide46$49,075
MounjaroTirzepatide40$42,980
OzempicSemaglutide23$31,393
TradjentaLinagliptin23$20,974
Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog31$20,255
Bydureon BciseExenatide Microspheres24$19,918
Tresiba Flextouch U-200Insulin Degludec20$15,238
EntrestoSacubitril/Valsartan32$12,523
MyrbetriqMirabegron16$10,915
Breo ElliptaFluticasone/Vilanterol15$8,845
Humulin 70/30 KwikpenInsulin Nph Hum/Reg Insulin Hm14$7,079

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$47$193,362221 claims
Boehringer IngelheimJardiance, Tradjenta$11$140,655142 claims
MerckJanuvia$114$87,28985 claims
Johnson & JohnsonXarelto$12$58,66552 claims
NovartisEntresto$22$12,52332 claims
Astellas Pharma US IncMyrbetriq$55$10,91516 claims
AstraZenecaSymbicort$22$2,52213 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 4,428 internal medicine providers in Ohio.

Other internal medicine in North Canton

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →